Intramuscular aripiprazole for the treatment of acute agitation in patients with schizophrenia or schizoaffective disorder: a double-blind, placebo-controlled comparison with intramuscular haloperidol

Author： Andrezina Raisa   Josiassen Richard   Marcus Ronald   Oren Dan   Manos George   Stock Elyse   Carson William   Iwamoto Taro  

Publisher： Springer Publishing Company

ISSN： 0033-3158

Source： Psychopharmacology, Vol.188, Iss.3, 2006-10, pp. : 281-292

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Seroquel TM treatment of hospitalised patients with acute exacerbation of subchronic or chronic schizophrenia. A multicentre, placebo-controlled, double-blind comparison of low and high dosage regimens

By Link C.G.G.   Arvanitis L.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 346-347

Elsevier

Access to resources Recommend Favorite

The Efficacy and Safety of Blonanserin Compared with Haloperidol in Acute-Phase Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled, Multicentre Study

By Garcia Esther  

CNS Drugs, Vol. 23, Iss. 7, 2009-07 ,pp. : 615-625

Adis International

Access to resources Recommend Favorite

Intramuscular (IM) ziprasidone 20 mg is effective in reducing acute agitation associated with psychosis: a double-blind, randomized trial

By Daniel David G.   Potkin Steven G.   Reeves Karen R.   Swift Rachel H.   Harrigan Edmund P.  

Psychopharmacology, Vol. 155, Iss. 2, 2001-05 ,pp. : 128-134

Springer Publishing Company

Access to resources Recommend Favorite

Randomized, controlled, double-blind, multicenter comparison of the cognitive effects of ziprasidone versus olanzapine in acutely ill inpatients with schizophrenia or schizoaffective disorder

By Harvey Philip   Siu Cynthia   Romano Steven  

Psychopharmacology, Vol. 172, Iss. 3, 2004-03 ,pp. : 324-332

Springer Publishing Company

Access to resources Recommend Favorite

Intramuscular Aripiprazole: A Review of its Use in the Management of Agitation in Schizophrenia and Bipolar I Disorder

By Sanford Mark   Scott Lesley J.  

CNS Drugs, Vol. 22, Iss. 4, 2008-01 ,pp. : 335-352

Adis International

Access to resources Recommend Favorite